In December2002, Anhui Biochem Pharmaceuticals Co., Ltd. was established in Taihe, Fuyang, Anhui, using chiral drug synthesis technology to develop anti-virus and anti-AIDS drugs.

In September2007 ,The foundation of Anhui Biochem United Pharmaceuticals' API production base was laid and officially started.

In April2008 ,Anhui Biochem Biopharmaceutical Co., Ltd. was established.

In March 2009, Anhui Biochem Medcial Sales Management Co., Ltd. passed the on-site inspection and thus formed a full-industry chain enterprise from the production of raw materials to the development and sales of finished products.

In January 2006, Development of anti-AIDS raw materials and preparations won the first prize of Anhui Science and Technology.

In November 2006 ,Intermediate CME process was recognized as the third prize of Anhui Science Progress Award.

In January 2009 ,Dideoxythiocytidine salicylate was recognized as the second prize of Anhui Scientific Progress Award.

In November 2009, the synthesis process of amino alcohol succinate was recognized as the third prize of Anhui Science Progress Award.

In September 2016,won the Anhui Labor Security Integrity Demonstration Unit.

In March 2017, it was evaluated as “Anhui Key Laboratory of Antiviral Drugs” by the Department of Science and Technology.

In November 2017,Pilot Enterprise for Integrated Development of Manufacturing and Internet in Anhui Province.

In December 2017, won the special and special small and medium-sized enterprises in Anhui Province.

In October 2018,won the national post-doctoral research station.

In November 2018 "Entecavir Dispersible Tablets" passed the consistency evaluation of generic drugs, making it the first one in Anhui Province to pass the consistency evaluation.

In December 2018, Awarded National Intellectual Property Advantage Enterprise.

In December 2018,Passed national IP management system certification.

In January 2019,"Tenofovir Disoproxil fumarate tablets" passed the consistency evaluation of generic drugs.

In January 2019,"Lamivudine Tenofovir Tablets" was approved for marketing with the approval number: Sinopharm Standard H20193014, which is another national exclusive AIDS product for our company.

In May 2019, Passed the assessment of the integrated management system of the two industries.

In December 2019 Won the National Enterprise Technology Center

In November 2020, it was approved as a national specialized and special "little giant" enterprise

In November 2020, it was approved as a high-end brand cultivation enterprise of Anhui Manufacturing Industry

March 2021, anti-hepatitis B drug Entecavir and its preparation development won the third prize of Anhui Provincial Science and Technology Progress Award

In August 2021, the invention patent of "a preparation method of Tenofovir" won the Anhui Provincial Patent Excellence Award

In December 2021, won the Anhui Province Consumer goods industry "three products" demonstration enterprise

In December 2021, it was selected as Anhui Export Brand

March 2022, Anhui Smart Factory - Smart factory for the production of apis and pharmaceutical intermediates

March 2022, Anhui Province Science and Technology third Prize - AIDS hepatitis B antiviral drug tenofovir bulk drug and series of preparations of key process development

September 2022, National Intellectual Property Demonstration Enterprise

In September 2022, Anhui Province Patent Gold Award - Efeverun tablet and its preparation method

November 2022, 2022 Anhui Provincial key leading enterprise of agricultural industrialization

December 2022, Anhui export brand - Bellazi